大塚ホールディングスの株価時系列
日付 | 始値 | 高値 | 安値 | 終値 | 前日比 | 騰落率 | 出来高 |
---|---|---|---|---|---|---|---|
2021/01/07 | 4,377 | 4,393 | 4,304 | 4,322 | -7 | -0.2% | 1,247,500 |
2021/01/06 | 4,279 | 4,334 | 4,260 | 4,329 | +60 | +1.4% | 545,800 |
2021/01/05 | 4,344 | 4,357 | 4,261 | 4,269 | -48 | -1.1% | 577,500 |
2021/01/04 | 4,402 | 4,404 | 4,300 | 4,317 | -101 | -2.3% | 522,900 |
2020/12/30 | 4,493 | 4,493 | 4,418 | 4,418 | -77 | -1.7% | 555,400 |
2020/12/29 | 4,417 | 4,497 | 4,404 | 4,495 | +21 | +0.5% | 855,900 |
2020/12/28 | 4,502 | 4,522 | 4,461 | 4,474 | +2 | ±0% | 904,200 |
2020/12/25 | 4,496 | 4,502 | 4,468 | 4,472 | +11 | +0.2% | 492,400 |
2020/12/24 | 4,465 | 4,489 | 4,455 | 4,461 | ±0 | ±0% | 463,500 |
2020/12/23 | 4,481 | 4,485 | 4,450 | 4,461 | +18 | +0.4% | 542,600 |
2020/12/22 | 4,457 | 4,495 | 4,439 | 4,443 | -57 | -1.3% | 673,900 |
2020/12/21 | 4,491 | 4,500 | 4,444 | 4,500 | +21 | +0.5% | 591,000 |
2020/12/18 | 4,405 | 4,485 | 4,404 | 4,479 | +67 | +1.5% | 1,033,900 |
2020/12/17 | 4,400 | 4,444 | 4,389 | 4,412 | +5 | +0.1% | 565,000 |
2020/12/16 | 4,461 | 4,477 | 4,403 | 4,407 | -17 | -0.4% | 713,600 |
2020/12/15 | 4,489 | 4,499 | 4,415 | 4,424 | -55 | -1.2% | 599,800 |
2020/12/14 | 4,448 | 4,512 | 4,440 | 4,479 | +54 | +1.2% | 798,100 |
2020/12/11 | 4,402 | 4,437 | 4,382 | 4,425 | +24 | +0.5% | 955,900 |
2020/12/10 | 4,385 | 4,406 | 4,372 | 4,401 | -7 | -0.2% | 713,800 |
2020/12/09 | 4,350 | 4,414 | 4,335 | 4,408 | +78 | +1.8% | 763,500 |
2020/12/08 | 4,355 | 4,355 | 4,319 | 4,330 | -67 | -1.5% | 657,200 |
2020/12/07 | 4,406 | 4,422 | 4,377 | 4,397 | +29 | +0.7% | 459,200 |
2020/12/04 | 4,358 | 4,402 | 4,349 | 4,368 | +30 | +0.7% | 667,000 |
2020/12/03 | 4,303 | 4,370 | 4,297 | 4,338 | +15 | +0.3% | 795,200 |
2020/12/02 | 4,297 | 4,336 | 4,278 | 4,323 | +30 | +0.7% | 1,058,600 |
2020/12/01 | 4,312 | 4,318 | 4,227 | 4,293 | +51 | +1.2% | 1,056,000 |
2020/11/30 | 4,393 | 4,401 | 4,196 | 4,242 | -150 | -3.4% | 2,205,400 |
2020/11/27 | 4,393 | 4,418 | 4,346 | 4,392 | ±0 | ±0% | 1,274,100 |
2020/11/26 | 4,370 | 4,392 | 4,331 | 4,392 | -11 | -0.2% | 918,700 |
2020/11/25 | 4,444 | 4,447 | 4,400 | 4,403 | +8 | +0.2% | 932,600 |
2020/11/24 | 4,367 | 4,443 | 4,357 | 4,395 | +70 | +1.6% | 1,146,300 |
2020/11/20 | 4,284 | 4,325 | 4,280 | 4,325 | +2 | ±0% | 659,200 |
2020/11/19 | 4,264 | 4,323 | 4,244 | 4,323 | +28 | +0.7% | 1,025,600 |
2020/11/18 | 4,350 | 4,358 | 4,265 | 4,295 | -9 | -0.2% | 1,021,600 |
2020/11/17 | 4,260 | 4,324 | 4,237 | 4,304 | +71 | +1.7% | 1,214,500 |
2020/11/16 | 4,244 | 4,280 | 4,209 | 4,233 | -39 | -0.9% | 1,333,300 |
2020/11/13 | 4,338 | 4,366 | 4,255 | 4,272 | -108 | -2.5% | 1,248,400 |
2020/11/12 | 4,336 | 4,396 | 4,318 | 4,380 | +43 | +1% | 1,264,600 |
2020/11/11 | 4,398 | 4,402 | 4,325 | 4,337 | +40 | +0.9% | 1,165,200 |
2020/11/10 | 4,323 | 4,346 | 4,262 | 4,297 | +102 | +2.4% | 1,201,500 |
2020/11/09 | 4,205 | 4,211 | 4,171 | 4,195 | +13 | +0.3% | 832,200 |
2020/11/06 | 4,120 | 4,192 | 4,097 | 4,182 | -5 | -0.1% | 841,000 |
2020/11/05 | 4,139 | 4,197 | 4,101 | 4,187 | +97 | +2.4% | 1,228,800 |
2020/11/04 | 4,091 | 4,114 | 4,028 | 4,090 | +100 | +2.5% | 1,050,400 |
2020/11/02 | 3,919 | 4,004 | 3,918 | 3,990 | +135 | +3.5% | 768,100 |
2020/10/30 | 3,950 | 3,952 | 3,848 | 3,855 | -127 | -3.2% | 1,252,100 |
2020/10/29 | 3,948 | 4,013 | 3,914 | 3,982 | -32 | -0.8% | 788,400 |
2020/10/28 | 4,026 | 4,044 | 4,004 | 4,014 | -33 | -0.8% | 832,900 |
2020/10/27 | 4,071 | 4,074 | 4,032 | 4,047 | -6 | -0.1% | 485,900 |
2020/10/26 | 4,073 | 4,101 | 4,042 | 4,053 | -17 | -0.4% | 316,500 |
951~
1000
件表示中 / 3412件
類似銘柄と比較する
現在ご覧いただいている「大塚HD」と類似性の高い銘柄をピックアップ。投資家が注目しているデータで比較できるようになっています。銘柄選びの参考情報としてご活用ください。
銘柄名 | 最低購入代金 | 売上高 成長率 |
経常 増益率 |
配当 利回り |
PER | PBR | 直近のチャート | 特色 |
---|---|---|---|---|---|---|---|---|
大塚HD | 891,000円 | +14.4% | +120.8% | 1.35% | 20.00倍 | 1.83倍 |
|
国内製薬大手で抗精神病薬が主力。ポカリスエットなど機能性食品も拡大。世界90カ所に工場 |
第一三共 | 443,500円 | +14.3% | +20.1% | 1.35% | 37.27倍 | 5.17倍 |
|
国内製薬大手。循環器と感染症薬強い。英アストラゼネカ社と提携し、がん領域の開拓中 |
武 田 | 411,300円 | +5.1% | +76.2% | 4.77% | 95.87倍 | 0.94倍 |
|
国内製薬首位。がん、中枢神経、消化器、希少疾患等に重点。巨額買収で世界売上上位10強入り |
アステラス薬 | 156,200円 | +12.2% | +180.3% | 4.74% | 55.93倍 | 1.83倍 |
|
医薬品国内2位。開発技術起点の研究開発体制。前立腺がん薬が柱。遺伝子・細胞治療技術育成 |
塩野義 | 209,400円 | +5.7% | +3.9% | 2.74% | 10.42倍 | 1.38倍 |
|
抗HIV薬が大型製品に。感染症、疼痛・中枢神経領域に強み。米国に積極展開。欧州、アジア開拓 |
市場注目の銘柄
チャート関連のコラム